Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group v secretory phospholipase A 2

Indian Journal of Biochemistry and Biophysics

Volumn 43, Issue 3, 2006, Pages 154-159

  OmPraba, G ^a   Velmurugan, D ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

HVPLA2 inhibitor; Indole analogs; Me indoxam; Phospholipase A2; QSAR

Indexed keywords

ENZYME INHIBITOR; GROUP V SECRETORY PHOSPHOLIPASE A2; INDOLE DERIVATIVE; PHOSPHOLIPASE A;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; ENZYME ACTIVE SITE; HUMAN; IN VITRO STUDY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

CATALYTIC DOMAIN; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; INDOLES; MODELS, CHEMICAL; PHOSPHOLIPASES A; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33749172710     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dennis E A (1997) Trends Biochem Sci 22, 1-2
2. Six D A & Dennis E A (2000) Biochim Biophys Acta 1488, 1-19
3. Kudo I & Murakami M (2002) Prostaglandins, other Lipid Mediators 68-69, 3-58
4. Condrea E, Yang C C & Rosenberg P (1981) Thromb Hemostasis 45, 82-89
5. Mebs D (1986) Toxicon 24, 161-168
6. Gutierrez J M & Lomonte B (1995) Toxicon 33, 1405-1424
7. Chang C C, Lee C Y, Eaker D & Fohlman J (1977) Toxicon 15, 571-576
8. Bon C, Changeux J P, Jeng T W & Fraenkel-Conrat H (1979) Eur J Biochem 9, 471-481
9. Fletcher J E, Rapuano B E, Condrea E, Yang C C & Rosenberg P (1981) Toxic Appl Pharmac 59, 375-382
10. Yuan Y, Jackson S P, Mitchell C A & Salem H H (1993) Thromb Res 70, 471-481
11. Gerrard J M, Robinson P, Narvey M & McNicol A (1993) Biochem cell Biol 71, 9-10 & 432-439
12. Chang J, Musser J H & McGregor H (1987) Biochem Pharmacol 36, 2429-2436
13. Goetzel E J, Dolezalova H, Gong Y, Hu Y L, Jaffe R B, Kalli K R & Conover C A (1999) Cancer Res 59, 5370-5375
14. Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, Sasagawa T, Lapushin R, Yu S, Jaffe R B, Wiener J R, Erickson J R & Mills G B (2000) Ann N Y Acad Sci 905, 188-208
15. Yedgar S, Lichtenberg D & Schnitzer E (2000) Biochim Biophys Acta 1488, 182-187
16. Benrezzouk R, Terencio M C, Ferrándiz M L, San Feliciano A, Gordaliza M, Miguel del Corral J M, de la Puente M L & Alcaraz M J (1999) Pharmacol Lett 64, 19, 205-211
17. Balasubramanya R, Chandra V, Kaur P & Singh T P (2005) Biochim Biophys Acta 1752, 177-85
18. Sekar K, Vaijayanthi Mala S, Yogavel M, Velmurugan D, Poi M J, Vishwanath B S, Gowda T V, Arokia Jeyaprakash A & Tsai M D (2003) J Mol Biol 333, 367-376
19. Giannini C, Debitus C, Posadas I, Payá M & D'Auria M V (2000) Tetrahedron Lett 41, 3257-3260
20. Volpon L, Besson F & Lancelin J M (2000) FEBS Lett 485, 76-80
21. Farooqui A A, Litsky M L, Farooqui T & Horrocks L A, (1999) Brain Res Bull 49, 3, 139-153
22. Chandra V, Jasti J, Kaur P, Ch. Betzel, Srinivasan A & Singh T P (2002) J Mol Biol 320, 215-222
23. Balsinde J, Baiboa M A, Insel P A & Dennis E A (1999) Annu Rev Pharmacol Toxicol 39, 175-89
24. Schevitz R W, Bach N J, Carlson D G, Chirgadze N Y & Clawson D K (1995) Nat Struct Biol 2, 458-465
25. Mihelich E D & Schevitz R W (1999) Biochim Biophys Acta 1441, 223-228
26. Dillard R D, Bach N J, Draheim S E, Berry D R & Carlson D G (1996) J Med Chem 39, 5119-5136
27. Draheim S E, Bach N J, Dillard R D, Berry D R & Carlson D G (1996) J Med Chem 39, 5159-5175
28. Smart B P, Pan Y H, Weeks A K, Bollinger J G, Bahnson B J & Gelb M H (2004) Bioorg Med Chem 12, 1737-1749
29. Balboa M A, Balsinde J, Winstead M V, Tischfield J A & Dennis E A (1996) J Biol Chem 271, 32381-32384
30. Gill P, Murray W & Wright M (1981) Practical Optimization, Academic Press, London
31. Bajorath J (2001) J Chem Inf Comput Sci 41, 233-245
32. st edn, Chap. 10, pp. 160-174, CRC Press Inc., London
33. Manivannan E, Prasanna S & Chaturvedi S C (2004) Indian J Biochem Biophys 41, 179-183